Vitamin-D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients
Laurence Orchard, Matthew Baldry, Myra Nasim-Mohi, Chantelle Monck, Kordo Saeed, Michael P W Grocott, Dushianthan Ahilanandan
Clinical Chemistry and Laboratory Medicine (CCLM), doi:10.1515/cclm-2020-1567
Objectives: The pattern of global COVID-19 has caused many to propose a possible link between susceptibility, severity and vitamin-D levels. Vitamin-D has known immune modulatory effects and deficiency has been linked to increased severity of viral infections. Methods: We evaluated patients admitted with confirmed SARS-COV-2 to our hospital between March-June 2020. Demographics and outcomes were assessed for those admitted to the intensive care unit (ICU) with normal (>50 nmol/L) and low (<50 nmol/L) vitamin-D. Results: There were 646 SARS-COV-2 PCR positive hospitalisations and 165 (25.5%) had plasma vitamin-D levels. Fifty patients were admitted to ICU. There was no difference in vitamin-D levels of those hospitalised (34, IQR 18.5-66 nmol/L) and those admitted to the ICU (31.5, IQR 21-42 nmol/L). Higher proportion of vitamin-D deficiency (<50 nmol/L) noted in the ICU group (82.0 vs. 65.2%). Among the ICU patients, low vitamin D level (<50 nmol/L) was associated with younger age (57 vs. 67 years, p=0.04) and lower cycle threshold (CT) real time polymerase chain reaction values (RT-PCR) (26.96 vs. 33.6, p=0.02) analogous to higher viral loads. However, there were no significant differences in ICU clinical outcomes (invasive and non-invasive mechanical ventilation, acute kidney injury and mechanical ventilation and hospital days) between patients with low and normal vitamin-D levels. Conclusions: Despite the association of low vitamin-D levels with low CT values, there is no difference in clinical outcomes in this small cohort of critically ill COVID-19 patients. The complex relationship between vitamin-D levels and COVID-19 infection needs further exploration with large scale randomized controlled trials.
References
Adams, Ren, Liu, Chun, Lagishetty et al., Vitamin D-directed rheostatic regulation of monocyte antibacterial responses, J Immunol
Almerighi, Sinistro, Cavazza, Ciaprini, Rocchi et al., 1alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes, Cytokine
Anwar, Hamdy, Taher, Fawzy, Abdulattif et al., Burden and outcome of vitamin D deficiency among critically ill patients: a prospective study, Nutr Clin Pract
Aygun, Vitamin D can prevent COVID-19 infection-induced multiple organ damage, Naunyn-Schmiedeberg's Arch Pharmacol
Barlow, Svoboda, Mackellar, Nash, York et al., Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37, PloS One
Bates, Lennox, Prentice, Bates, Swan, National diet and nutrition survey
Chandran, Maung, Mithal, Parameswaran, Vitamin D in COVID-19: dousing the fire or averting the storm? -a perspective from the Asia-Pacific, Osteoporos Sarcopenia,
doi:10.1016/j.afos.2020.07.003Charoenngam, Holick, Immunologic effects of vitamin D on human health and disease, Nutrients,
doi:10.3390/nu12072097D'avolio, Avataneo, Manca, Cusato, Nicolò et al., 25-hhydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients,
doi:10.3390/nu12051359Dancer, Parekh, Lax, Souza, Zheng et al., Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS), Thorax
Hastie, Mackay, Ho, Celis-Morales, Katikireddi et al., Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr
Huang, Ran, Lv, Feng, Ran et al., Chronological changes of viral shedding in adult inpatients with COVID-19 in Wuhan, China, Clin Infect Dis,
doi:10.1093/cid/ciaa631Im, Je, Baek, Chung, Kwon et al., Nutritional status of patients with coronavirus disease 2019 (COVID-19), Int J Infect Dis,
doi:10.1016/j.ijid.2020.08.018Kellum, Lameire, Aspelin, Barsoum, Burdmann et al., Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury, Kidney Int Suppl
Lofgren, Fefferman, Naumov, Gorski, Naumova, Influenza seasonality: underlying causes and modeling theories, J Virol
Meltzer, Best, Zhang, Vokes, Arora et al., Association of vitamin D deficiency and treatment with COVID-19 incidence, medRxiv,
doi:10.1101/2020.05.08.20095893Merzon, Tworowski, Gorohovski, Vinker, Cohen et al., Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli populationbased study, FEBS J,
doi:10.1111/febs.15495Mitchell, Vitamin-D and COVID-19: do deficient risk a poorer outcome?, Lancet Diabetes Endocrinol
Nice, COVID-19 rapid evidence summary: vitamin D for COVID-19 advice NICE
Panagiotou, Tee, Ihsan, Athar, Marchitelli et al., Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity, Clin Endocrinol,
doi:10.1111/cen.14276Pham, Rahman, Majidi, Waterhouse, Neale, Acute respiratory tract infection and 25-hydroxyvitamin D concentration: a systematic review and meta-analysis, Int J Environ Res Publ Health
Quesada-Gomez, Entrenas-Castillo, Bouillon, Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: revised Ms SBMB 2020_166, J Steroid Biochem Mol Biol
Raisi-Estabragh, Mccracken, Bethell, Cooper, Cooper et al., Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1,326 cases from the UK Biobank, J Public Health,
doi:10.1093/pubmed/fdaa095Rao, Manissero, Steele, Pareja, A narrative systematic review of the clinical utility of cycle threshold values in the context of COVID-19, Infect Dis Ther
Rech, Hunsaker, Rodriguez, Deficiency in 25-hydroxyvitamin D and 30-day mortality in patients with severe sepsis and septic shock, Am J Crit Care
Rosa, Malaguarnera, Nicoletti, Malaguarnera, Vitamin D3: a helpful immuno-modulator, Immunology
Tabary, Khanmohammadi, Araghi, Dadkhahfar, Tavangar, Pathologic features of COVID-19: a concise review, Pathol Res Pract
Weir, Thenappan, Bhargava, Chen, Does vitamin D deficiency increase the severity of COVID-19?, Clin Med
Xu, Yang, Chen, Luo, Zhang et al., Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system, Mol Med Rep
Yu, Yan, Wang, Yang, Wang et al., Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients, Clin Infect Dis,
doi:10.1093/cid/ciaa345Yuki, Fujiogi, Koutsogiannaki, COVID-19 pathophysiology: a review, Clin Immunol
Zhang, Leung, Richers, Liu, Remigio et al., Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1, J Immunol
DOI record:
{
"DOI": "10.1515/cclm-2020-1567",
"ISSN": [
"1434-6621",
"1437-4331"
],
"URL": "http://dx.doi.org/10.1515/cclm-2020-1567",
"abstract": "<jats:title>Abstract</jats:title>\n <jats:sec id=\"j_cclm-2020-1567_abs_001\">\n <jats:title>Objectives</jats:title>\n <jats:p>The pattern of global COVID-19 has caused many to propose a possible link between susceptibility, severity and vitamin-D levels. Vitamin-D has known immune modulatory effects and deficiency has been linked to increased severity of viral infections.</jats:p>\n </jats:sec>\n <jats:sec id=\"j_cclm-2020-1567_abs_002\">\n <jats:title>Methods</jats:title>\n <jats:p>We evaluated patients admitted with confirmed SARS-COV-2 to our hospital between March-June 2020. Demographics and outcomes were assessed for those admitted to the intensive care unit (ICU) with normal (>50 nmol/L) and low (<50 nmol/L) vitamin-D.</jats:p>\n </jats:sec>\n <jats:sec id=\"j_cclm-2020-1567_abs_003\">\n <jats:title>Results</jats:title>\n <jats:p>There were 646 SARS-COV-2 PCR positive hospitalisations and 165 (25.5%) had plasma vitamin-D levels. Fifty patients were admitted to ICU. There was no difference in vitamin-D levels of those hospitalised (34, IQR 18.5–66 nmol/L) and those admitted to the ICU (31.5, IQR 21–42 nmol/L). Higher proportion of vitamin-D deficiency (<50 nmol/L) noted in the ICU group (82.0 vs. 65.2%). Among the ICU patients, low vitamin D level (<50 nmol/L) was associated with younger age (57 vs. 67 years, p=0.04) and lower cycle threshold (CT) real time polymerase chain reaction values (RT-PCR) (26.96 vs. 33.6, p=0.02) analogous to higher viral loads. However, there were no significant differences in ICU clinical outcomes (invasive and non-invasive mechanical ventilation, acute kidney injury and mechanical ventilation and hospital days) between patients with low and normal vitamin-D levels.</jats:p>\n </jats:sec>\n <jats:sec id=\"j_cclm-2020-1567_abs_004\">\n <jats:title>Conclusions</jats:title>\n <jats:p>Despite the association of low vitamin-D levels with low CT values, there is no difference in clinical outcomes in this small cohort of critically ill COVID-19 patients. The complex relationship between vitamin-D levels and COVID-19 infection needs further exploration with large scale randomized controlled trials.</jats:p>\n </jats:sec>",
"alternative-id": [
"10.1515/cclm-2020-1567"
],
"author": [
{
"affiliation": [
{
"name": "General Intensive Care Unit , University Hospital Southampton NHS Foundation Trust , Southampton , UK"
}
],
"family": "Orchard",
"given": "Laurence",
"sequence": "first"
},
{
"affiliation": [
{
"name": "General Intensive Care Unit , University Hospital Southampton NHS Foundation Trust , Southampton , UK"
}
],
"family": "Baldry",
"given": "Matthew",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "General Intensive Care Unit , University Hospital Southampton NHS Foundation Trust , Southampton , UK"
}
],
"family": "Nasim-Mohi",
"given": "Myra",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Southampton Specialist Virology Centre , University of Southampton School of Medicine, University Hospital Southampton NHS Foundation Trust , Southampton , UK"
}
],
"family": "Monck",
"given": "Chantelle",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Microbiology Innovation and Research Unit, Department of Microbiology , University Hospital Southampton NHS Foundation Trust , Southampton , UK"
},
{
"name": "Faculty of Medicine , University of Southampton University, Hospital Southampton , Southampton , UK"
}
],
"family": "Saeed",
"given": "Kordo",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "General Intensive Care Unit , University Hospital Southampton NHS Foundation Trust , Southampton , UK"
},
{
"name": "Faculty of Medicine , University of Southampton University, Hospital Southampton , Southampton , UK"
},
{
"name": "NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre , University Hospital Southampton/University of Southampton , Southampton , UK"
}
],
"family": "Grocott",
"given": "Michael P. W.",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "General Intensive Care Unit , University Hospital Southampton NHS Foundation Trust , Southampton , UK"
},
{
"name": "Faculty of Medicine , University of Southampton University, Hospital Southampton , Southampton , UK"
},
{
"name": "NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre , University Hospital Southampton/University of Southampton , Southampton , UK"
}
],
"family": "Ahilanandan",
"given": "Dushianthan",
"sequence": "additional"
}
],
"container-title": "Clinical Chemistry and Laboratory Medicine (CCLM)",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2021,
1,
23
]
],
"date-time": "2021-01-23T06:33:46Z",
"timestamp": 1611383626000
},
"deposited": {
"date-parts": [
[
2021,
8,
22
]
],
"date-time": "2021-08-22T02:04:42Z",
"timestamp": 1629597882000
},
"indexed": {
"date-parts": [
[
2024,
2,
21
]
],
"date-time": "2024-02-21T09:44:19Z",
"timestamp": 1708508659716
},
"is-referenced-by-count": 30,
"issue": "6",
"issued": {
"date-parts": [
[
2021,
1,
19
]
]
},
"journal-issue": {
"issue": "6",
"published-online": {
"date-parts": [
[
2021,
1,
15
]
]
},
"published-print": {
"date-parts": [
[
2021,
5,
26
]
]
}
},
"language": "en",
"link": [
{
"URL": "https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-1567/article-10.1515-cclm-2020-1567.xml",
"content-type": "text/html",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://www.degruyter.com/document/doi/10.1515/cclm-2020-1567/xml",
"content-type": "application/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://www.degruyter.com/document/doi/10.1515/cclm-2020-1567/pdf",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "374",
"original-title": [],
"page": "1155-1163",
"prefix": "10.1515",
"published": {
"date-parts": [
[
2021,
1,
19
]
]
},
"published-online": {
"date-parts": [
[
2021,
1,
19
]
]
},
"published-print": {
"date-parts": [
[
2021,
5,
26
]
]
},
"publisher": "Walter de Gruyter GmbH",
"reference": [
{
"DOI": "10.1016/j.prp.2020.153097",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_001",
"unstructured": "Tabary, M, Khanmohammadi, S, Araghi, F, Dadkhahfar, S, Tavangar, S. Pathologic features of COVID-19: a concise review. Pathol Res Pract 2020;216:153097. https://doi.org/10.1016/j.prp.2020.153097."
},
{
"DOI": "10.1056/NEJMoa2021436",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_002",
"unstructured": "Group, TRC. Dexamethasone in hospitalized patients with Covid-19 — preliminary report. N Engl J Med 2020 Jul 17. https://doi.org/10.1056/NEJMoa2021436 [Epub ahead of print]."
},
{
"DOI": "10.1016/j.clim.2020.108427",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_003",
"unstructured": "Yuki, K, Fujiogi, M, Koutsogiannaki, S. COVID-19 pathophysiology: a review. Clin Immunol 2020;215:108427. https://doi.org/10.1016/j.clim.2020.108427."
},
{
"DOI": "10.1016/j.afos.2020.07.003",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_004",
"unstructured": "Chandran, M, Maung, AC, Mithal, A, Parameswaran, R. Vitamin D in COVID-19: dousing the fire or averting the storm? – a perspective from the Asia-Pacific. Osteoporos Sarcopenia 2020 Jul 23. https://doi.org/10.1016/j.afos.2020.07.003 [Epub ahead of print]."
},
{
"DOI": "10.1016/j.ijid.2020.08.018",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_005",
"unstructured": "Im, JH, Je, YS, Baek, J, Chung, MH, Kwon, HY, Lee, JS. Nutritional status of patients with coronavirus disease 2019 (COVID-19). Int J Infect Dis 2020 Aug 11. https://doi.org/10.1016/j.ijid.2020.08.018 [Epub ahead of print]."
},
{
"DOI": "10.1016/S2213-8587(20)30183-2",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_006",
"unstructured": "Mitchell, F. Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol 2020;8:570. https://doi.org/10.1016/s2213-8587(20)30183-2."
},
{
"DOI": "10.7861/clinmed.2020-0301",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_007",
"unstructured": "Weir, EK, Thenappan, T, Bhargava, M, Chen, Y. Does vitamin D deficiency increase the severity of COVID-19? Clin Med 2020;20:e107–8. https://doi.org/10.7861/clinmed.2020-0301."
},
{
"DOI": "10.3390/ijerph16173020",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_008",
"unstructured": "Pham, H, Rahman, A, Majidi, A, Waterhouse, M, Neale, RE. Acute respiratory tract infection and 25-hydroxyvitamin D concentration: a systematic review and meta-analysis. Int J Environ Res Publ Health 2019;16:3020. https://doi.org/10.3390/ijerph16173020."
},
{
"DOI": "10.1128/JVI.01680-06",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_009",
"unstructured": "Lofgren, E, Fefferman, NH, Naumov, YN, Gorski, J, Naumova, EN. Influenza seasonality: underlying causes and modeling theories. J Virol 2007;81:5429–36. https://doi.org/10.1128/jvi.01680-06."
},
{
"key": "2021082201593403749_j_cclm-2020-1567_ref_010",
"unstructured": "NICE. COVID-19 rapid evidence summary: vitamin D for COVID-19 advice NICE. Available from: https://www.nice.org.uk/advice/es28/chapter/Key-messages [Accessed 7 Sep 2020]."
},
{
"DOI": "10.1038/kisup.2012.1",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_011",
"unstructured": "Kellum, JA, Lameire, N, Aspelin, P, Barsoum, RS, Burdmann, EA, Goldstein, SL, et al.. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:1–138. https://doi.org/10.1038/kisup.2012.1."
},
{
"key": "2021082201593403749_j_cclm-2020-1567_ref_012",
"unstructured": "Bates, B, Lennox, A, Prentice, A, Bates, C, Swan, G. National diet and nutrition survey; 2011. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/207708/NDNS-Y3-report_All-TEXT-docs-combined.pdf."
},
{
"DOI": "10.1111/cen.14276",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_013",
"unstructured": "Panagiotou, G, Tee, SA, Ihsan, Y, Athar, W, Marchitelli, G, Kelly, D, et al.. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity. Clin Endocrinol 2020 Jul 3. https://doi.org/10.1111/cen.14276 [Epub ahead of print]."
},
{
"DOI": "10.1136/thoraxjnl-2014-206680",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_014",
"unstructured": "Dancer, RCA, Parekh, D, Lax, S, D’Souza, V, Zheng, S, Bassford, CR, et al.. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax 2015;70:617–24. https://doi.org/10.1136/thoraxjnl-2014-206680."
},
{
"DOI": "10.4037/ajcc2014723",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_015",
"unstructured": "Rech, MA, Hunsaker, T, Rodriguez, J. Deficiency in 25-hydroxyvitamin D and 30-day mortality in patients with severe sepsis and septic shock. Am J Crit Care 2014;23:e72–9. https://doi.org/10.4037/ajcc2014723."
},
{
"DOI": "10.1177/0884533616671741",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_016",
"unstructured": "Anwar, E, Hamdy, G, Taher, E, Fawzy, E, Abdulattif, S, Attia, MH. Burden and outcome of vitamin D deficiency among critically ill patients: a prospective study. Nutr Clin Pract 2017;32:378–84. https://doi.org/10.1177/0884533616671741."
},
{
"DOI": "10.21203/rs.3.rs-41867/v1",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_017",
"unstructured": "Rao, SN, Manissero, D, Steele, VR, Pareja, J. A narrative systematic review of the clinical utility of cycle threshold values in the context of COVID-19. Infect Dis Ther 2020;9:1–14. https://doi.org/10.1007/s40121-020-00324-3."
},
{
"DOI": "10.1093/cid/ciaa631",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_018",
"unstructured": "Huang, J-T, Ran, R-X, Lv, Z-H, Feng, LN, Ran, CY, Tong, YQ, et al.. Chronological changes of viral shedding in adult inpatients with COVID-19 in Wuhan, China. Clin Infect Dis 2020 May 23. https://doi.org/10.1093/cid/ciaa631 [Epub ahead of print]."
},
{
"DOI": "10.1093/cid/ciaa345",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_019",
"unstructured": "Yu, F, Yan, L, Wang, N, Yang, S, Wang, L, Tang, Y, et al.. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. Clin Infect Dis 2020 Mar 28. https://doi.org/10.1093/cid/ciaa345 [Epub ahead of print]."
},
{
"DOI": "10.1007/s00210-020-01911-4",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_020",
"unstructured": "Aygun, H. Vitamin D can prevent COVID-19 infection-induced multiple organ damage. Naunyn-Schmiedeberg’s Arch Pharmacol 2020;393:1157–60. https://doi.org/10.1007/s00210-020-01911-4."
},
{
"DOI": "10.3892/mmr.2017.7546",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_021",
"unstructured": "Xu, J, Yang, J, Chen, J, Luo, Q, Zhang, Q, Zhang, H. Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol Med Rep 2017;16:7432. https://doi.org/10.3892/mmr.2017.7546."
},
{
"DOI": "10.1016/j.jsbmb.2020.105719",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_022",
"unstructured": "Quesada-Gomez, JM, Entrenas-Castillo, M, Bouillon, R. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: revised Ms SBMB 2020_166. J Steroid Biochem Mol Biol 2020;202:105719. https://doi.org/10.1016/j.jsbmb.2020.105719."
},
{
"DOI": "10.3390/nu12072097",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_023",
"unstructured": "Charoenngam, N, Holick, MF. Immunologic effects of vitamin D on human health and disease. Nutrients 2020 Jul 15;12. https://doi.org/10.3390/nu12072097 [Epub ahead of print]."
},
{
"DOI": "10.4049/jimmunol.0803736",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_024",
"unstructured": "Adams, JS, Ren, S, Liu, PT, Chun, RF, Lagishetty, V, Gombart, AF, et al.. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 2009;182:4289–95. https://doi.org/10.4049/jimmunol.0803736."
},
{
"DOI": "10.1016/j.cyto.2008.12.009",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_025",
"unstructured": "Almerighi, C, Sinistro, A, Cavazza, A, Ciaprini, C, Rocchi, G, Bergamini, A, et al.. 1alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 2009;45:190–7. https://doi.org/10.1016/j.cyto.2008.12.009."
},
{
"DOI": "10.4049/jimmunol.1102412",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_026",
"unstructured": "Zhang, Y, Leung, DYM, Richers, BN, Liu, Y, Remigio, LK, Riches, DW, et al.. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 2012;188:2127–35. https://doi.org/10.4049/jimmunol.1102412."
},
{
"DOI": "10.1111/j.1365-2567.2011.03482.x",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_027",
"unstructured": "Di Rosa, M, Malaguarnera, M, Nicoletti, F, Malaguarnera, L. Vitamin D3: a helpful immuno-modulator. Immunology 2011;134:123–39. https://doi.org/10.1111/j.1365-2567.2011.03482.x."
},
{
"DOI": "10.1371/journal.pone.0025333",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_028",
"unstructured": "Barlow, PG, Svoboda, P, Mackellar, A, Nash, AA, York, I, Pohl, J, et al.. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PloS One 2011;6:e25333. https://doi.org/10.1371/journal.pone.0025333."
},
{
"DOI": "10.1101/2020.05.08.20095893",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_029",
"unstructured": "Meltzer, DO, Best, TJ, Zhang, H, Vokes, T, Arora, V, Solway, J. Association of vitamin D deficiency and treatment with COVID-19 incidence. medRxiv 2020 May 13. https://doi.org/10.1101/2020.05.08.20095893 [Epub ahead of print]."
},
{
"DOI": "10.3390/nu12051359",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_030",
"unstructured": "D’Avolio, A, Avataneo, V, Manca, A, Cusato, J, De Nicolò, A, Lucchini, R, et al.. 25-hhydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients 2020 May 9;12. https://doi.org/10.3390/nu12051359 [Epub ahead of print]."
},
{
"DOI": "10.1101/2020.07.01.20144329",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_031",
"unstructured": "Merzon, E, Tworowski, D, Gorohovski, A, Vinker, S, Cohen, AG, Green, I, et al.. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J 2020 Jul 23. https://doi.org/10.1111/febs.15495 [Epub ahead of print]."
},
{
"DOI": "10.1016/j.dsx.2020.07.021",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_032",
"unstructured": "Hastie, CE, Mackay, DF, Ho, F, Celis-Morales, CA, Katikireddi, SV, Niedzwiedz, CL, et al.. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr 2020;14:561–5. https://doi.org/10.1016/j.dsx.2020.04.050."
},
{
"DOI": "10.1101/2020.06.26.20140921",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_033",
"unstructured": "Hastie, CE, Pell, JP, Sattar, N. Vitamin D and COVID-19 infection and mortality in UK Biobank. Eur J Nutr 2020 Aug 26. https://doi.org/10.1007/s00394-020-02372-4 [Epub ahead of print]."
},
{
"DOI": "10.1101/2020.06.01.20118943",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_034",
"unstructured": "Raisi-Estabragh, Z, McCracken, C, Bethell, MS, Cooper, J, Cooper, C, Caulfield, MJ, et al.. Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1,326 cases from the UK Biobank. J Public Health 2020 Jun 19. https://doi.org/10.1093/pubmed/fdaa095 [Epub ahead of print]."
},
{
"DOI": "10.1136/postgradmedj-2020-138712",
"doi-asserted-by": "crossref",
"key": "2021082201593403749_j_cclm-2020-1567_ref_035",
"unstructured": "Baktash, V, Hosack, T, Patel, N, Shah, S, Kandiah, P, Van Den Abbeele, K, et al.. Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J 2020 Aug 27. https://doi.org/10.1136/postgradmedj-2020-138712 [Epub ahead of print]."
}
],
"reference-count": 35,
"references-count": 35,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.degruyter.com/document/doi/10.1515/cclm-2020-1567/html"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Biochemistry (medical)",
"Clinical Biochemistry",
"General Medicine"
],
"subtitle": [],
"title": "Vitamin-D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients",
"type": "journal-article",
"volume": "59"
}
